Showing results (1-10 of 640) with videos related to
Sort By:
Pageof 64
Neurourology and Urodynamics|January 17, 2020
Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reportingMarjan Amiri, Sandra Murgas, Andreas Stang, et al.Journal of Clinical Medicine|January 20, 2021
Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional SettingMarjan Amiri, Tim Schneider, Matthias Oelke, et al.British Journal of Clinical Pharmacology|March 26, 2021
Statistical inference in abstracts of three influential clinical pharmacology journals analyzed using a text-mining algorithmMarjan Amiri, Markus Deckert, Martin C Michel, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 28, 2015
Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industryMarjan Amiri, Martin C MichelNaunyn-Schmiedeberg'S Archives of Pharmacology|June 22, 2018
Do review articles boost journal impact factors? A longitudinal analysis for five pharmacology journalsMarjan Amiri, Martin C MichelNeurourology and Urodynamics|May 20, 2022
Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatmentSandra Schönburg, Sandra Murgas, Paolo Fornara, et al.World Journal of Urology|February 18, 2011
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional studyMatthias Oelke, Sandra Murgas, Ina Baumann, et al.Frontiers in Pharmacology|April 17, 2023
Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patientsA Elif Müderrisoglu, Ayse A Sakul, Sandra Murgas, et al.Research and Reports in Urology|January 31, 2019
Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in GermanySandra Murgas, Daniela AdolfAdvances in Therapy|March 24, 2022
What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with PropiverineA Elif Müderrisoglu, Matthias Oelke, Tim Schneider, et al.Pageof 64